VisionHealth's Kata® Clinical app to support sterna biologicals' clinical Phase Ila asthma trial Kata® Clinical app supports Phase Ila proof-of-concept study investigating sterna biologicals' lead compound SB010 in moderate to severe asthma patients Kata® Clinical will be used to enhance inhaler device handling and therapy adherence, reduce drop-out rates and...

VisionHealth adds Clinical Trial Function to Kata® App supporting and optimizing inhalation therapy of chronic lung diseases Kata® Clinical, the new specialized version of Kata® offers clinical trial specific extended functionality Kata® Clinical can be customized to partners’ needs; options include data management and result validation, patient management, inhalation training and monitoring, recording...

VisionHealth raises 1.5 million Euro for DiGA pivotal study and market preparation of inhalation therapy app Kata® Consortium of existing shareholders supports financing and welcomes two new investors Funds will be used for regulatory approval and commercial launch of the Kata® app in Germany Garching (Germany), February 26, 2021 – VisionHealth GmbH,...

VisionHealth and major regional insurer AOK Bayern to start pilot on Kata® digital health app for severe asthma and COPD supporting inhalation therapy Innovative digital healthcare app Kata® available for the first time to patients covered by statutory health insurance With Kata®, Bavaria’s largest statutory health insurance fund can provide...

Health App Kata® receives VISION.A Award Gold in the category “Best innovation on the healthcare market” The VISION.A Awards were presented for the fifth time on 25 June 2020. Our inhalation trainer was awarded for the category “Best Innovation in the Healthcare Market”. In this category, innovative treatment approaches that shape the...